RecruitingNCT02456974

Antibiotic Dosing in Pediatric Intensive Care


Sponsor

University Hospital, Ghent

Enrollment

640 participants

Start Date

May 1, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

Pharmacokinetics of antibiotics in critically ill neonates, infants and children


Eligibility

Min Age: 1 DayMax Age: 16 Years

Plain Language Summary

Simplified for easier understanding

This study monitors how antibiotic levels in the blood change over time in critically ill children in the intensive care unit (ICU). Children's bodies process medications differently than adults, and illness can further change this. By tracking drug levels, researchers want to find the most effective and safe antibiotic dosing for very young and seriously ill patients. You may be eligible if: - You are a patient (newborn to 15 years old, weight at least 1.8 kg) admitted to a pediatric ICU - You are receiving one of the studied antibiotics (such as vancomycin, meropenem, ciprofloxacin, or others) as part of your treatment - You have an intravenous or arterial line available for blood sampling You may NOT be eligible if: - You do not have a catheter in place for blood sampling - Your parent or guardian has not given consent - You have a known allergy to the class of antibiotics being studied - You are on extracorporeal support such as dialysis or ECMO Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREblood sampling in patients receiving amoxicillin-clavulanate as part of routine clinical care
PROCEDUREblood sampling in patients receiving piperacilline-tazobactam as part of routine clinical care.
PROCEDUREblood sampling in patients receiving vancomycin as part of routine clinical care.
PROCEDUREblood sampling in patients receiving teicoplanin as part of routine clinical care.
PROCEDUREblood sampling in patients receiving meropenem as part of routine clinical care.
PROCEDUREblood sampling and urine smapling in patients receiving ciprofloxacin as part of routine clinical care.
PROCEDUREblood sampling in patients receiving amikacin as part of routine clinical care.

Locations(1)

Ghent University Hospital, Hospital Pharmacy

Ghent, Belgium

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02456974


Related Trials